MKI67 and neoplasm: Specifically, while anti‐PD1 therapy alone modestly decreased Ki67 levels, the combination with PCIF1 knockout further suppressed cellular proliferation, implying that the absence of PCIF1 sensitizes tumours to immunotherapy.